课题基金 / 基金详情

Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer

Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer
通过建立新的前列腺癌转基因小鼠模型来表征新型前列腺癌因子接触蛋白 1 (CNTN1) 衍生的肿瘤发生
批准号:
488928
负责人:
Tang Damu
金额:
$61.02万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2028-09-01

项目摘要

项目成果

Tang Damu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PC) affects one in six men and is the second leading cause of cancer-associated deaths in Canadian men. Mortality is caused by cancer progression. A major progression is recurrence following initial therapy. Recurrent PCs have higher ris
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PCSK9, a novel contributor to the development of castration resistant prostate cancer
  • 批准号:
    389512
  • 项目类别:
    Operating Grants
  • 资助金额:
    $42.08万
  • 财政年份:
    2018
  • 负责人:
    Tang Damu
  • 依托单位:
Investigation of Shank-interacting protein-like 1 (SIPL1)-mediated PTEN inactivation during breast tumorigenesis
  • 批准号:
    207777
  • 项目类别:
    Operating Grants
  • 资助金额:
    $27.27万
  • 财政年份:
    2010
  • 负责人:
    Tang Damu
  • 依托单位:
Characterization of AKF-PD-mediated protection of diabetic nephropathy in db/db mice
  • 批准号:
    203977
  • 项目类别:
    Operating Grants
  • 资助金额:
    $10.45万
  • 财政年份:
    2010
  • 负责人:
    Tang Damu
  • 依托单位:
Investigation of Shank-interacting protein-like 1 (SIPL1)-mediated PTEN inactivation during breast tumorigenesis
  • 批准号:
    205080
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2009
  • 负责人:
    Tang Damu
  • 依托单位:
海外基金